white coat investor

In this final installment of our four-part deep dive, we conclude our review of White Coat Investor’s critique of the Ernst & Young whitepaper on insurance products. If you’ve stuck with us from Episode 315 through now, you know this has been a winding journey through annuities, whole life policies, investment assumptions—and plenty of eyebrow-raising…

In Part 3 of our deep dive into White Coat Investor Disagrees with Ernst & Young, we tackle some of the strangest assumptions in the analysis. We break down how whole life policies are managed (or mismanaged), questionable projections of policy performance, and bizarre reinvestment strategies for annuity proceeds. Plus, we explore the odd decision…